Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Sidney Reilly who wrote (1503)	10/21/1998 12:28:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

"Recently, however, the largest vaccine manufacturer in the world decided that it is interested in buying this small company's product to the tune of $31 million plus $900,000 up front. Further, the worlds largest vaccine manufacturer wants to buy 1.3 million shares at a price that would be about 97% higher than today's closing price." The deadline for announcing whether or not this deal will go through is October 30, 1998.

To: Sidney Reilly who wrote (1503)	10/22/1998 11:24:00 AM
From: Walter Morton	Read Replies (2) \| Respond to of 2742

Just nine days left...tick tock...tick tock...

To: Sidney Reilly who wrote (1503)	10/22/1998 12:31:00 PM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

Is this a big if: "On June 30th 1998, Cistron and Pasteur Merieux Connaught executed a letter of intent to grant Pasteur Merieux Connaught a three-year option to enter into an exclusive, worldwide license with Cistron. If the option is exercised, the option and license agreement could be worth in excess of 33 million to Cistron, assuming that products attain regulatory approval."